95 related articles for article (PubMed ID: 26676388)
1. Muscarinic Receptor Binding of Imidafenacin in the Human Bladder Mucosa and Detrusor and Parotid Gland.
Seki M; Ogoda M; Kuraoka S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
Low Urin Tract Symptoms; 2011 Sep; 3(2):64-8. PubMed ID: 26676388
[TBL] [Abstract][Full Text] [Related]
2. Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle.
Yoshida A; Fuchihata Y; Kuraoka S; Osano A; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
Urology; 2013 Apr; 81(4):920.e1-5. PubMed ID: 23497983
[TBL] [Abstract][Full Text] [Related]
3. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
Yoshida A; Seki M; Nasrin S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Ehlert FJ; Yamada S
Urology; 2011 Sep; 78(3):721.e7-721.e12. PubMed ID: 21777958
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor binding of the novel radioligand, [3h]imidafenacin in the human bladder and parotid gland.
Yoshida A; Kuraoka S; Ito Y; Okura T; Deguchi Y; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
J Pharmacol Sci; 2014; 124(1):40-6. PubMed ID: 24389821
[TBL] [Abstract][Full Text] [Related]
5. Characterization of muscarinic receptor binding by the novel radioligand, [(3)H]imidafenacin, in the bladder and other tissues of rats.
Kuraoka S; Ito Y; Wakuda H; Shinozuka K; Onoue S; Yamada S
J Pharmacol Sci; 2016 Jul; 131(3):184-9. PubMed ID: 27430986
[TBL] [Abstract][Full Text] [Related]
6. Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.
Yamada S; Seki M; Ogoda M; Fukata A; Nakamura M; Ito Y
J Pharmacol Exp Ther; 2011 Feb; 336(2):365-71. PubMed ID: 21047953
[TBL] [Abstract][Full Text] [Related]
7. Characterization of muscarinic and P2X receptors in the urothelium and detrusor muscle of the rat bladder.
Ogoda M; Ito Y; Fuchihata Y; Onoue S; Yamada S
J Pharmacol Sci; 2016 May; 131(1):58-63. PubMed ID: 27174863
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic Receptor Binding in Rat Bladder Urothelium and Detrusor Muscle by Intravesical Solifenacin.
Ito Y; Kashiwabara M; Yoshida A; Hikiyama E; Onoue S; Yamada S
Biol Pharm Bull; 2016; 39(7):1167-71. PubMed ID: 27374291
[TBL] [Abstract][Full Text] [Related]
10. Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder.
Maruyama S; Oki T; Otsuka A; Shinbo H; Ozono S; Kageyama S; Mikami Y; Araki I; Takeda M; Masuyama K; Yamada S
J Urol; 2006 Jan; 175(1):365-9. PubMed ID: 16406943
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.
Yoshida A; Maruyama S; Fukumoto D; Tsukada H; Ito Y; Yamada S
Life Sci; 2010 Jul; 87(5-6):175-80. PubMed ID: 20598326
[TBL] [Abstract][Full Text] [Related]
12. Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E
J Pharmacol Exp Ther; 2009 Mar; 328(3):893-9. PubMed ID: 19029429
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
Waldeck K; Larsson B; Andersson KE
J Urol; 1997 Mar; 157(3):1093-7. PubMed ID: 9072550
[TBL] [Abstract][Full Text] [Related]
15. Urinary Excretion Contributes to Long-Lasting Blockade of Bladder Muscarinic Receptors by Imidafenacin: Effect of Bilateral Ureteral Ligation.
Ito Y; Kuraoka S; Endo S; Takahashi A; Onoue S; Yamada S
J Pharmacol Exp Ther; 2017 Jan; 360(1):69-74. PubMed ID: 27831487
[TBL] [Abstract][Full Text] [Related]
16. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.
Mansfield KJ; Liu L; Mitchelson FJ; Moore KH; Millard RJ; Burcher E
Br J Pharmacol; 2005 Apr; 144(8):1089-99. PubMed ID: 15723094
[TBL] [Abstract][Full Text] [Related]
18. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
[TBL] [Abstract][Full Text] [Related]
20. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
